# Control Atlas — Progress Tracker

This document tracks all Atlas Entries in chronological order.
Each entry represents a **scientifically meaningful state transition**, not a visualization experiment.

---

## Completed Entries

### ✅ Atlas Entry #005 — The Blockade
- **Question:** Can KRAS bind RAF when locked by AMG 510?
- **Answer:** No. Drug-bound topology sterically excludes the effector.
- **Structures:** 6OIM (Drug), 4G0N (RAF)
- **Status:** Complete

### ✅ Atlas Entry #001 — Wild-Type Baseline
- **Question:** What does inactive KRAS look like?
- **Answer:** A compact, non-signaling conformation.
- **Structures:** WT KRAS (GDP)
- **Status:** Complete

### ✅ Atlas Entry #002 — KRAS G12C Circuit
- **Question:** How does G12C alter internal signaling geometry?
- **Answer:** Switch regions adopt an active-compatible topology.
- **Structures:** KRAS G12C
- **Status:** Complete

### ✅ Atlas Entry #003 — Drug-Bound KRAS G12C
- **Question:** How does AMG 510 inhibit KRAS?
- **Answer:** By enforcing a sterically locked conformation.
- **Structures:** KRAS G12C + AMG 510 (6OIM)
- **Status:** Complete

### ✅ Atlas Entry #004 — RAF Effector Coupling
- **Question:** Can KRAS recruit RAF?
- **Answer:** Yes. A precise protein–protein interface forms.
- **Structures:** Ras–RAF complex (4G0N)
- **Status:** Complete

### ✅ Atlas Entry #006 — The Variant Gap
- **Question:** Why is G12D undruggable with G12C inhibitors?
- **Answer:** Chemical incompatibility at the atomic level (Sulfur vs Oxygen).
- **Structures:** 6OIM (G12C), 4DSN (G12D)
- **Status:** Complete
